Michihiro Takahashi
Michihiro Takahashi publishes mostly in Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience, on topics such as Schizophrenia research and treatment, Bipolar Disorder and Treatment and Attention Deficit Hyperactivity Disorder.
- World rank
- #6,017,881 of 7,710,434 ranked researchers
- Rank in Japan
- #223,945 of 383,136
- Works
- 32
- Citations
- 522
- Citations per work
- 16.3
What does Michihiro Takahashi research?
Michihiro Takahashi's work is mostly in Medicine (48%), Neuroscience (14%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1548.3%
- Medicine1548.3%
- Everything else1032.6%
- Life Sciences619.1%
- 1Psychiatry and Mental health35% of their works
- 2Pharmacology9% of their works
- 3Cognitive Neuroscience9% of their works
- 4Molecular Biology6% of their works
- 5Cellular and Molecular Neuroscience4% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Attention Deficit Hyperactivity Disorder
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
- Autism Spectrum Disorder Research
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Neuroethics, Human Enhancement, Biomedical Innovations
Which keywords describe Michihiro Takahashi's research?
The keywords of their largest research topics: Genetics, Neurobiology, Prevalence, Antipsychotic Drugs, Brain Imaging, Depression, Neurocognitive Deficits and Bipolar Spectrum Disorder.
- Cognitive Enhancement
- Cognitive-Behavioral Therapy
- Anxiety Disorders
- Ketamine
- Antidepressant
- ADHD
- Bipolar Spectrum Disorder
- Depression
- Antipsychotic Drugs
- Neurobiology
- Genetics
- Prevalence
- Brain Imaging
- Neurocognitive Deficits
- Treatment Guidelines
- Attention-Deficit/Hyperactivity Disorder
- Electroconvulsive Therapy
- Serotonin Syndrome
- Autism Spectrum Disorders
- Neurodevelopmental Disorders
- Neuroenhancement
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Genetics193 topics
- Neurobiology152 topics
- Prevalence152 topics
- Antipsychotic Drugs101 topic
- Brain Imaging102 topics
- Depression102 topics
- Neurocognitive Deficits101 topic
- Bipolar Spectrum Disorder81 topic
- Treatment Guidelines81 topic
- ADHD71 topic
- Attention-Deficit/Hyperactivity Disorder71 topic
- Antidepressant51 topic
- Electroconvulsive Therapy51 topic
- Ketamine51 topic
- Serotonin Syndrome51 topic
- Anxiety Disorders41 topic
- Autism Spectrum Disorders41 topic
- Cognitive-Behavioral Therapy41 topic
- Neurodevelopmental Disorders41 topic
- Cognitive Enhancement31 topic
- Neuroenhancement31 topic
Where does Michihiro Takahashi work?
Michihiro Takahashi's main affiliation in the publication record is Eli Lilly (Japan), Japan.
How many publications and citations does Michihiro Takahashi have?
OpenAlex counts 32 works and 522 citations for Michihiro Takahashi, an h-index of 12, ranking #6,017,881 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michihiro Takahashi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.